2 C
New York
Wednesday, February 1, 2023

Value Investing Philosophy And VistaGen Therapeutics Inc. (NASDAQ: VTGN)?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for VistaGen Therapeutics Inc. (VTGN) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.001, or -0.55%, to $0.18. The VistaGen Therapeutics Inc. has recorded 44,363 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Vistagen Announces First Participants Dosed in Phase 1 Clinical Trial of PH10, an Investigational Pherine Nasal Spray for Major Depressive Disorder.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


Stocks Info

VTGN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.18 and fluctuated between $0.1855 as its day high and $0.1754 as its day low. The current market capitalization of VistaGen Therapeutics Inc. is $33.98M. A total of 3.52 million shares were traded on the day, compared to an average of 6.00M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, VTGN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 8 BUYs and 1 SELLs from insiders. Insiders purchased 1,215,000 shares during that period but sold 60,000.

In the most recent transaction, GIN JERRY B bought 100,000 shares of VTGN for 0.18 per share on Aug 18. After the transaction, the Director now owns 100,000 company shares. In a previous transaction on Aug 18, GIN JERRY B bought 100,000 shares at 0.18 per share. VTGN shares that Director owns now total 100,000.

Among the insiders who bought shares, Singh Shawn acquired of 600,000 shares on Aug 17 at a per-share price of $0.17. This resulted in the CHIEF EXECUTIVE OFFICER holding 626,234 shares of VTGN after the transaction. In another insider transaction, Adler Reid G. bought 300,000 shares at $0.17 per share on Aug 17. Company shares held by the CHIEF LEGAL OFFICER now total 334,629.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for VTGN in the last 3 months, the mean price target is $0.25 with high estimates of $0.25 and low estimates of $0.25. In terms of 52-week highs and lows, VTGN has a high of $1.79 and a low of $0.08.

As of this writing, VTGN has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.1. The company reported an EPS of -$0.09 in the last quarter, which was -50.00% lower than expectations of -$0.06.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 2 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VTGN is Buy with a score of 3.00. A total of 0 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles